Changes in S-100 protein serum levels in survivors of out of hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study
Open Access
- 1 January 2009
- journal article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 13 (2), R58-7
- https://doi.org/10.1186/cc7785
Abstract
Knowledge about the influence of current neuroprotective interventions on prognostic markers after survival from cardiac arrest is lacking. This study aimed to investigate the effects of mild therapeutic hypothermia on the release of the astroglial protein S-100 after cardiopulmonary resuscitation (CPR) in survivors of out-of-hospital cardiac arrest. This was a prospective, observational study performed during a two-year period, involving medical emergency services and five collaborating hospitals at the city of Aachen, Germany. Sixty-eight subjects were enrolled by the emergency physician on duty by taking blood samples after successful attempts at resuscitation with return of spontaneous circulation (ROSC), followed by samples at 6, 12, 24, 72 and 120 hours post ROSC by the appropriate intensive care unit staff. Depending on the decision of the attending physician, subjects were cooled down to 33°C (n = 37) for 24 hours or were held at 37°C (n = 31). Patients were tracked for estimating mortality and gross neurological outcome for 14 days. S-100 levels in patients not receiving mild therapeutic hypothermia (normothermia (NT)) showed equivalent numbers as compared with cooled patients (mild therapeutic hypothermia (MTH)) on baseline (NT = 1.38 μg/l versus MTH = 1.30 μg/l; P = 0.886). S-100 levels on baseline were significantly lower in patients with a good neurological outcome at 14 days after the event in comparison to their peers with adverse outcome (P = 0.014). Although the difference in S-100 levels of MTH patients with adverse or favourable neurological outcome reached statistical significance, it did not in NT patients. Although the predictive power of S-100 levels were best on admission but not at later time points, MTH had no influence on S-100 serum levels in survivors of non-traumatic out-of-hospital cardiac arrest in the particular setting of this investigation.Keywords
This publication has 35 references indexed in Scilit:
- Neurological injury markers in children with septic shock*Pediatric Critical Care Medicine, 2008
- Prediction of cognitive dysfunction after resuscitation from out-of-hospital cardiac arrest using serum neuron-specific enolase and protein S-100Heart, 2007
- European Resuscitation Council Guidelines for Resuscitation 2005: Section 4. Adult advanced life supportResuscitation, 2005
- Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma ScaleResuscitation, 2005
- The evolution of serum astroglial S-100 β protein in patients with cardiac arrest treated with mild hypothermiaResuscitation, 2005
- Cognitive impairment in survivors of out-of-hospital cardiac arrestAmerican Heart Journal, 2004
- Serum Neuron-Specific Enolase and S-100B Protein in Cardiac Arrest Patients Treated With HypothermiaStroke, 2003
- Mild Therapeutic Hypothermia to Improve the Neurologic Outcome after Cardiac ArrestThe New England Journal of Medicine, 2002
- Treatment of Comatose Survivors of Out-of-Hospital Cardiac Arrest with Induced HypothermiaThe New England Journal of Medicine, 2002
- Increased Serum Levels of the S-100 Protein Are Associated With Hypoxic Brain Damage After Cardiac ArrestStroke, 1998